-
1
Utilization of patient-reported outcomes to assess adherence to relugolix when combined with stereotactic body radiation therapy for intermediate to high-risk prostate cancer
Published 2025-01-01Subjects: “…SBRT (stereotactic body radiation therapy)…”
Get full text
Article